Literature DB >> 11527641

Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? Insights from a population-based study.

Y Agmon1, B K Khandheria, I Meissner, J R Sicks, W M O'Fallon, D O Wiebers, J P Whisnant, J B Seward, A J Tajik.   

Abstract

OBJECTIVES: The aim of this study was to examine the association between atherosclerosis risk factors, aortic atherosclerosis and aortic valve abnormalities in the general population.
BACKGROUND: Clinical and experimental studies suggest that aortic valve sclerosis (AVS) is a manifestation of the atherosclerotic process.
METHODS: Three hundred eighty-one subjects, a sample of the Olmsted County (Minnesota) population, were examined by transthoracic and transesophageal echocardiography. The presence of AVS (thickened valve leaflets), elevated transaortic flow velocities and aortic regurgitation (AR) was determined. The associations between atherosclerosis risk factors, aortic atherosclerosis (imaged by transesophageal echocardiography) and aortic valve abnormalities were examined.
RESULTS: Age, male gender, body mass index (odds ratio [OR]: 1.07 per kg/m(2); 95% confidence interval [CI]: 1.02 to 1.12), antihypertensive treatment (OR: 1.93; CI: 1.12 to 3.32) and plasma homocysteine levels (OR: 1.89 per twofold increase; CI: 0.99 to 3.61) were independently associated with an increased risk of AVS. Age, body mass index and pulse pressure (OR: 1.21 per 10 mm Hg; CI: 1.00 to 1.46) were associated with elevated (upper quintile) transaortic velocities, whereas only age was independently associated with AR. Sinotubular junction sclerosis (p = 0.001) and atherosclerosis of the ascending aorta (p = 0.03) were independently associated with AVS and elevated transaortic velocities, respectively.
CONCLUSIONS: Atherosclerosis risk factors and proximal aortic atherosclerosis are independently associated with aortic valve abnormalities in the general population. These observations suggest that AVS is an atherosclerosis-like process involving the aortic valve.

Entities:  

Mesh:

Year:  2001        PMID: 11527641     DOI: 10.1016/s0735-1097(01)01422-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  53 in total

1.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

2.  Persistent endothelial dysfunction in calcified aortic stenosis beyond valve replacement surgery.

Authors:  R Chenevard; M Bechir; D Hurlimann; F Ruschitzka; J Turina; T F Luscher; G Noll
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

3.  Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

Authors:  Luis M Moura; Sandra F Ramos; José L Zamorano; Isabel M Barros; Luis F Azevedo; Francisco Rocha-Gonçalves; Nalini M Rajamannan
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

4.  Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study.

Authors:  Takashi Hisamatsu; Katsuyuki Miura; Akira Fujiyoshi; Aya Kadota; Naoko Miyagawa; Atsushi Satoh; Maryam Zaid; Takashi Yamamoto; Minoru Horie; Hirotsugu Ueshima
Journal:  Atherosclerosis       Date:  2018-03-22       Impact factor: 5.162

5.  Relation between progression of aortic valve sclerosis and carotid intima-media thickening in asymptomatic subjects with cardiovascular risk factors.

Authors:  Yasuko Yamaura; Nozomi Watanabe; Kikuko Obase; Akihiro Hayashida; Hiroyuki Okura; Kiyoshi Yoshida
Journal:  J Echocardiogr       Date:  2010-03-11

6.  Does aortic valve sclerosis predicts the severity and complexity of coronary artery disease?

Authors:  Hemal Bhatt; Dharmesh Sanghani; Kell Julliard; George Fernaine
Journal:  Indian Heart J       Date:  2015-04-27

7.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

Authors:  Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

8.  The Contribution of Whole Blood Viscosity to the Process of Aortic Valve Sclerosis.

Authors:  Alper Sercelik; Abbas Fikret Besnili
Journal:  Med Princ Pract       Date:  2018-02-08       Impact factor: 1.927

9.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

10.  Aortic Valve Sclerosis on Echocardiography is a Good Predictor of Coronary Artery Disease in Patients With an Inconclusive Treadmill Exercise Test.

Authors:  Dong-Bin Kim; Hae-Ok Jung; Doo-Soo Jeon; Chan-Seok Park; Sung-Won Jang; Hoon-Joon Park; Pum Joon Kim; Sang Hong Baek; Ki-Bae Seung; Tai-Ho Rho; Jae-Hyung Kim; Kyu-Bo Choi
Journal:  Korean Circ J       Date:  2009-07-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.